Literature DB >> 2043023

Extrapulmonary Pneumocystis carinii infections in the acquired immunodeficiency syndrome.

O J Cohen1, M Y Stoeckle.   

Abstract

Pneumocystis carinii is a frequent cause of interstitial pneumonitis in patients with cell-mediated immunodeficiencies. Extrapulmonary P carinii infection is a rare manifestation of disease caused by this organism. Nevertheless, reports of extrapulmonary P carinii infection are increasing in the setting of the acquired immunodeficiency syndrome (AIDS). We report two cases of extrapulmonary P carinii infection in patients with AIDS and review the literature on this subject. We identified 37 such cases: in 19 cases, P carinii pneumonia was present concurrently; in 18 cases, involvement was exclusively extrapulmonary. A minority of patients were receiving aerosolized pentamidine isethionate therapy. Most patients had a history of P carinii pneumonia, and other AIDS-related illnesses, such as cytomegalovirus infection, mycobacterial disease, candidiasis, Kaposi's sarcoma, and cryptococcosis were common. Concurrent cytomegalovirus infection indicated a poor prognosis, while otic pneumocytosis was associated with a favorable outcome. Pathologic evidence suggested that extrapulmonary pneumocystosis occurred by hematogenous and lymphatic dissemination from the lungs in most cases. In other cases, extrapulmonary pneumocystosis appeared to be due either to reactivation of latent infection in extrapulmonary sites or to primary infection of these sites. Further studies are needed to determine the true frequency of extrapulmonary involvement in P carinii infections and to define risk factors for acquisition of extrapulmonary pneumocytosis.

Entities:  

Mesh:

Year:  1991        PMID: 2043023

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

Review 1.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Pneumocystis carinii pneumonia after 40 years.

Authors:  M Nouza
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

3.  Disseminated Pneumocystis jirovecii Infection with Osteomyelitis in a Patient with CTLA-4 Haploinsufficiency.

Authors:  Aminaa E Siddiqi; Anne Y Liu; Gregory W Charville; Christian A Kunder; Gulbu Uzel; Amir A Sadighi Akha; Jean Oak; Beth Martin; Joshua Sacha; David B Lewis; Yael Gernez
Journal:  J Clin Immunol       Date:  2020-01-18       Impact factor: 8.317

4.  Identification of extrapulmonary Pneumocystis carinii in immunocompromised rats by PCR.

Authors:  S Chary-Reddy; D C Graves
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  Pneumocystis carinii meningoradiculitis in a patient with AIDS.

Authors:  J L Villanueva; E Cordero; F J Caballero-Granado; C Regordan; B Becerril; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

6.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques.

Authors:  Shulin Qin; Beth A F Junecko; Carissa M Lucero; Cynthia R Klamar; Anita M Trichel; Michael A Murphey-Corb; Patrick M Tarwater; Denise E Kirschner; Todd A Reinhart
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

8.  Gastrointestinal opportunistic infections in human immunodeficiency virus disease.

Authors:  Awadh R Al Anazi
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

9.  Pneumocystis carinii infection of the small intestine.

Authors:  K Kinchen; T H Kinchen; T Inglesby
Journal:  J Natl Med Assoc       Date:  1998-10       Impact factor: 1.798

Review 10.  Is Pneumocystis carinii a deep mycosis-like agent?

Authors:  E Dei-Cas; J C Cailliez; F Palluault; E M Aliouat; E Mazars; B Soulez; J Suppin; D Camus
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.